LOW-VOLUME · HOSP-HEAVY
nateglinide Side Effects
nateglinide (also sold as Starlix) is a LOW-VOLUME FAERS extract #479 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 40.9% mention hospitalization (532 reports).
Data updated 2026-05-15
- 1,302
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
nateglinide: 40.9% mention hospitalization (532 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #479 of 524 by FAERS report count.
Thinner FAERS extract for nateglinide (Starlix) (1,302 reports #479 of 524 by FAERS report count). 40.9% mention hospitalization (532 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
BLOOD GLUCOSE INCREASED leads 76 of 1,302 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (299 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (141 reports, 10.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 47 |
| LACTIC ACIDOSIS | 19 |
| RENAL FAILURE | 16 |
| CARDIAC ARREST | 15 |
| TOXICITY TO VARIOUS AGENTS | 14 |
| COMA | 11 |
| COMPLETED SUICIDE | 11 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 11 |
| RESPIRATORY FAILURE | 9 |
| BLOOD PRESSURE DECREASED | 7 |
| DIARRHOEA | 7 |
| DYSPNOEA | 7 |
| PNEUMONIA | 7 |
| RENAL FAILURE ACUTE | 7 |
| ACUTE KIDNEY INJURY | 6 |
| RENAL IMPAIRMENT | 6 |
| HEART RATE DECREASED | 5 |
| INTENTIONAL OVERDOSE | 5 |
| INTERSTITIAL LUNG DISEASE | 5 |
| MULTI-ORGAN FAILURE | 5 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (532, 40.9% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 34 |
| HYPOGLYCAEMIA | 30 |
| LACTIC ACIDOSIS | 30 |
| NAUSEA | 29 |
| RENAL FAILURE | 29 |
| FALL | 27 |
| PNEUMONIA | 27 |
| VOMITING | 27 |
| DECREASED APPETITE | 26 |
| DIARRHOEA | 23 |
| FATIGUE | 22 |
| PYREXIA | 22 |
| ACUTE KIDNEY INJURY | 20 |
| BLOOD GLUCOSE INCREASED | 20 |
| ASTHENIA | 17 |
| CHEST PAIN | 17 |
| DIZZINESS | 17 |
| HYPOTENSION | 17 |
| TOXICITY TO VARIOUS AGENTS | 16 |
| ABDOMINAL PAIN | 15 |
How to read nateglinide FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 1,302 voluntary reports linked to nateglinide (Starlix), 2004-2025. Death is listed on 141 (10.8%). Hospitalization appears on 532 (40.9%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with nateglinide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 1,275 FAERS cases (Δ 27 lighter vs nateglinide); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,256 FAERS cases (Δ 46 lighter vs nateglinide); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,220 FAERS cases (Δ 82 lighter vs nateglinide); DEATH-MARKED · HOSP-HEAVY · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,385 FAERS cases (Δ 83 heavier vs nateglinide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 51.3 pp vs nateglinide's DEATH-HEAVY): CASELOAD · HOSP-MID.
nateglinide stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.